Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives
Closed Posted
- Opportunity number
- MP-CPI-20-002
- Agency
-
Public Health Service
Department of Health and Human Services
- Applications due
- Award size
- $750,000 to $1,250,000
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Other
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
This notice solicits applications to demonstrate the feasibility and effectiveness of providing financial incentives to providers to improve the quality of life of children with sickle cell disease (SCD) through increased prescription rates of hydroxyurea. This initiative is not issued or funded by the Centers for Medicare and Medicaid Services (CMS).
Files
| File | Type | Posted |
|---|---|---|
| MP-CPI-20-002 FAQs FINAL.pdf | ||
| PKG00262806-instructions.pdf | ||
| MP-CPI-20-002 Hydroxyurea FOA.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity